Moresco RM - Search Results

1

Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics.

Taiarol L, Bigogno C, Sesana S, Kravicz M, Viale F, Pozzi E, Monza L, Carozzi VA, Meregalli C, Valtorta S, Moresco RM, Koch M, Barbugian F, Russo L, Dondio G, Steinkühler C, Re F. Taiarol L, et al. Among authors: moresco rm. Cancers (Basel). 2022 Jun 16;14(12):2978. doi: 10.3390/cancers14122978. Cancers (Basel). 2022. PMID: 35740641 Free PMC article.

2

Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET.

Cottone L, Valtorta S, Capobianco A, Belloli S, Rovere-Querini P, Fazio F, Manfredi AA, Moresco RM. Cottone L, et al. Among authors: moresco rm. J Nucl Med. 2011 Nov;52(11):1770-7. doi: 10.2967/jnumed.111.089177. J Nucl Med. 2011. PMID: 22045707 Free article.

3

The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis.

Beltrami E, Valtorta S, Moresco R, Marcu R, Belloli S, Fassina A, Fazio F, Pelicci P, Giorgio M. Beltrami E, et al. Curr Pharm Des. 2013;19(15):2708-14. doi: 10.2174/1381612811319150005. Curr Pharm Des. 2013. PMID: 23092318

4

Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.

Valtorta S, Belloli S, Sanvito F, Masiello V, Di Grigoli G, Monterisi C, Fazio F, Picchio M, Moresco RM. Valtorta S, et al. Among authors: moresco rm. J Nucl Med. 2013 Jul;54(7):1106-12. doi: 10.2967/jnumed.112.111120. Epub 2013 May 22. J Nucl Med. 2013. PMID: 23699667 Free article.

5

A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer.

Valtorta S, Nicolini G, Tripodi F, Meregalli C, Cavaletti G, Avezza F, Crippa L, Bertoli G, Sanvito F, Fusi P, Pagliarin R, Orsini F, Moresco RM, Coccetti P. Valtorta S, et al. Among authors: moresco rm. Invest New Drugs. 2014 Dec;32(6):1123-33. doi: 10.1007/s10637-014-0148-8. Epub 2014 Aug 19. Invest New Drugs. 2014. PMID: 25134489

6

VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells.

Curtarello M, Zulato E, Nardo G, Valtorta S, Guzzo G, Rossi E, Esposito G, Msaki A, Pastò A, Rasola A, Persano L, Ciccarese F, Bertorelle R, Todde S, Plebani M, Schroer H, Walenta S, Mueller-Klieser W, Amadori A, Moresco RM, Indraccolo S. Curtarello M, et al. Among authors: moresco rm. Cancer Res. 2015 Jan 1;75(1):120-33. doi: 10.1158/0008-5472.CAN-13-2037. Epub 2014 Nov 7. Cancer Res. 2015. PMID: 25381153

7

Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study.

Gaglio D, Valtorta S, Ripamonti M, Bonanomi M, Damiani C, Todde S, Negri AS, Sanvito F, Mastroianni F, Di Campli A, Turacchio G, Di Grigoli G, Belloli S, Luini A, Gilardi MC, Colangelo AM, Alberghina L, Moresco RM. Gaglio D, et al. Among authors: moresco rm. Oncotarget. 2016 Aug 9;7(32):52017-52031. doi: 10.18632/oncotarget.10470. Oncotarget. 2016. PMID: 27409831 Free PMC article.

8

Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.

Valtorta S, Moro M, Prisinzano G, Bertolini G, Tortoreto M, Raccagni I, Pastorino U, Roz L, Sozzi G, Moresco RM. Valtorta S, et al. Among authors: moresco rm. J Nucl Med. 2017 Jan;58(1):42-47. doi: 10.2967/jnumed.116.176404. Epub 2016 Oct 20. J Nucl Med. 2017. PMID: 27765858 Free article.

9

Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [¹⁸F]FDG Positron Emission Tomography and Autoradiography.

Putzu A, Valtorta S, Di Grigoli G, Haenggi M, Belloli S, Malgaroli A, Gemma M, Landoni G, Beretta L, Moresco RM. Putzu A, et al. Among authors: moresco rm. Neurocrit Care. 2018 Jun;28(3):370-378. doi: 10.1007/s12028-017-0445-0. Neurocrit Care. 2018. PMID: 28875429 Free article.

10

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models.

Valtorta S, Lo Dico A, Raccagni I, Gaglio D, Belloli S, Politi LS, Martelli C, Diceglie C, Bonanomi M, Ercoli G, Vaira V, Ottobrini L, Moresco RM. Valtorta S, et al. Among authors: moresco rm. Oncotarget. 2017 Dec 6;8(68):113090-113104. doi: 10.18632/oncotarget.23028. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page